Literature DB >> 17877368

Protein farnesyl transferase target selectivity is dependent upon peptide stimulated product release.

Jerry M Troutman1, Douglas A Andres, H Peter Spielmann.   

Abstract

Protein farnesyl transferase (FTase) catalyzes transfer of a 15 carbon farnesyl lipid to cysteine in the C-terminal Ca1a2X sequence of numerous proteins including Ras. Previous studies have shown that product release is rate limiting and is dependent on binding of either a new peptide or isoprenoid diphosphate substrate. While considerable progress has been made in understanding how FTase distinguishes between related target proteins, the relative importance of the two pathways for product release on substrate selectivity is unclear. A detailed analysis of substrate stimulated product release has now been performed and provides new insights into the mechanism of FTase target selectivity. To clarify how FTase selects between different Ca1a2X sequences, we have examined the competition of various peptide substrates for modification with the isoprenoids farnesyl diphosphate (FPP) and anilinogeranyl diphosphate (AGPP). We find that reactivity of some competing peptides is correlated with apparent Kmpeptide, while the reactivity of others is predicted by the selectivity factor apparent kcat/Kmpeptide. The peptide target selectivity also depends on the structure of the isoprenoid donor. Additionally, we observe two peptide substrate concentration dependent maxima and substrate inhibition in the steady-state reaction which require a minimum of three peptide binding states for the steady-state FTase reaction mechanism. We propose a model for the FTase reaction mechanism that, in addition to FPP stimulated product release, incorporates peptide binding to the FTase-FPP complex and the formation of an FTase-product-peptide complex followed by product release leading to an inhibitory FTase-peptide complex as a natural consequence of catalysis to explain these results.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17877368     DOI: 10.1021/bi700513n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.

Authors:  Thangaiah Subramanian; Suxia Liu; Jerry M Troutman; Douglas A Andres; H Peter Spielmann
Journal:  Chembiochem       Date:  2008-11-24       Impact factor: 3.164

2.  Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities.

Authors:  James L Hougland; Katherine A Hicks; Heather L Hartman; Rebekah A Kelly; Terry J Watt; Carol A Fierke
Journal:  J Mol Biol       Date:  2009-10-28       Impact factor: 5.469

3.  Protein Farnesyltransferase Catalyzes Unanticipated Farnesylation and Geranylgeranylation of Shortened Target Sequences.

Authors:  Sudhat Ashok; Emily R Hildebrandt; Colby S Ruiz; Daniel S Hardgrove; David W Coreno; Walter K Schmidt; James L Hougland
Journal:  Biochemistry       Date:  2020-03-10       Impact factor: 3.162

4.  Farnesyl diphosphate analogues with aryl moieties are efficient alternate substrates for protein farnesyltransferase.

Authors:  Thangaiah Subramanian; June E Pais; Suxia Liu; Jerry M Troutman; Yuta Suzuki; Karunai Leela Subramanian; Carol A Fierke; Douglas A Andres; H Peter Spielmann
Journal:  Biochemistry       Date:  2012-10-02       Impact factor: 3.162

5.  A tagging-via-substrate approach to detect the farnesylated proteome using two-dimensional electrophoresis coupled with Western blotting.

Authors:  Fredrick O Onono; Michael A Morgan; H Peter Spielmann; Douglas A Andres; Thangaiah Subramanian; Arnold Ganser; Christoph W M Reuter
Journal:  Mol Cell Proteomics       Date:  2010-01-26       Impact factor: 5.911

6.  Identification of a novel class of farnesylation targets by structure-based modeling of binding specificity.

Authors:  Nir London; Corissa L Lamphear; James L Hougland; Carol A Fierke; Ora Schueler-Furman
Journal:  PLoS Comput Biol       Date:  2011-10-06       Impact factor: 4.475

7.  Use of synthetic isoprenoids to target protein prenylation and Rho GTPases in breast cancer invasion.

Authors:  Min Chen; Teresa Knifley; Thangaiah Subramanian; H Peter Spielmann; Kathleen L O'Connor
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.